Literature DB >> 12394168

Cytokines, viruses, and graft-versus-host disease.

Ernst Holler1.   

Abstract

Proinflammatory cytokines released by host tissues during conditioning treatment and interferon gamma released from donor T cells play a major role in acute graft-versus-host disease (GVHD). In the past year the interaction of cytokines has been elucidated further. Host antigen-presenting cells play a key role in the induction of allogeneic recognition. Their activity is modulated by cytokines such as flt3-ligand, viruses, and donor T cells. Expansion of donor T cells is crucial for the pathogenesis of acute GVHD. Cytokines of the T helper 1 response-IFN-gamma, IL-12, and IL-18-regulate the expansion of donor and host cells via the induction of Fas and FasL and subsequent apoptosis. However TNF-alpha, FasL, and IL-1 also cause damage to target cells. Cytokine and receptor gene polymorphism has an impact on the activity of both host and donor cell activation. Genetic factors, conditioning treatment, lipopolysaccharides (LPS) from gram-negative microorganisms, viral infections, and donor T cells determine the activity level of host antigen-presenting cells and macrophages, which have an impact on acute GVHD and other complications of allogeneic stem cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12394168     DOI: 10.1097/00062752-200211000-00002

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  10 in total

1.  Adenosine A₂A receptor agonist-mediated increase in donor-derived regulatory T cells suppresses development of graft-versus-host disease.

Authors:  Kyu Lee Han; Stephenie V M Thomas; Sherry M Koontz; Cattlena M Changpriroa; Seung-Kwon Ha; Harry L Malech; Elizabeth M Kang
Journal:  J Immunol       Date:  2012-12-07       Impact factor: 5.422

2.  Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.

Authors:  Pavan Reddy; Yoshinobu Maeda; Kevin Hotary; Chen Liu; Leonid L Reznikov; Charles A Dinarello; James L M Ferrara
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-04       Impact factor: 11.205

3.  Blockade of Vascular Endothelial Growth Factor (VEGF) Aggravates the Severity of Acute Graft-versus-host Disease (GVHD) after Experimental Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT).

Authors:  Ai-Ran Kim; Ji-Young Lim; Dae Chul Jeong; Gyeongsin Park; Byung Churl Lee; Chang-Ki Min
Journal:  Immune Netw       Date:  2011-12-31       Impact factor: 6.303

4.  Polymorphism in clinical immunology - From HLA typing to immunogenetic profiling.

Authors:  Ping Jin; Ena Wang
Journal:  J Transl Med       Date:  2003-11-18       Impact factor: 5.531

Review 5.  TLR/MyD88-mediated Innate Immunity in Intestinal Graft-versus-Host Disease.

Authors:  Young-Kwan Lee; Myungsoo Kang; Eun Young Choi
Journal:  Immune Netw       Date:  2017-06-20       Impact factor: 6.303

6.  Targeting SLP76:ITK interaction separates GVHD from GVL in allo-HSCT.

Authors:  Mahinbanu Mammadli; Weishan Huang; Rebecca Harris; Hui Xiong; Samuel Weeks; Adriana May; Teresa Gentile; Jessica Henty-Ridilla; Adam T Waickman; Avery August; Alaji Bah; Mobin Karimi
Journal:  iScience       Date:  2021-03-11

7.  Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) Differentiates GVL and GVHD in Allo-HSCT.

Authors:  Mahinbanu Mammadli; Weishan Huang; Rebecca Harris; Aisha Sultana; Ying Cheng; Wei Tong; Jeffery Pu; Teresa Gentile; Shanti Dsouza; Qi Yang; Alaji Bah; Avery August; Mobin Karimi
Journal:  Front Immunol       Date:  2020-11-26       Impact factor: 7.561

8.  Interleukin-2-inducible T-cell kinase (Itk) signaling regulates potent noncanonical regulatory T cells.

Authors:  Mahinbanu Mammadli; Rebecca Harris; Liye Suo; Adriana May; Teresa Gentile; Adam T Waickman; Alaji Bah; Avery August; Elmar Nurmemmedov; Mobin Karimi
Journal:  Clin Transl Med       Date:  2021-12

9.  Graft-versus-host disease is enhanced by selective CD73 blockade in mice.

Authors:  Long Wang; Jie Fan; Siqi Chen; Yi Zhang; Tyler J Curiel; Bin Zhang
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

10.  Acute Renal Graft-Versus-Host Disease in a Murine Model of Allogeneic Bone Marrow Transplantation.

Authors:  Peter M Schmid; Abdellatif Bouazzaoui; Karin Schmid; Christoph Birner; Christian Schach; Lars S Maier; Ernst Holler; Dierk H Endemann
Journal:  Cell Transplant       Date:  2017-08       Impact factor: 4.064

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.